Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging

OBJECTIVE: Parkinson disease is characterized by motor and nonmotor symptoms, reduced striatal dopamine signaling, and loss of dopamine neurons in the substantia nigra. It is now known that the pathological process in Parkinson disease may begin decades before the clinical diagnosis and include a va...

Descripción completa

Detalles Bibliográficos
Autores principales: Matuskey, David, Tinaz, Sule, Wilcox, Kyle C., Naganawa, Mika, Toyonaga, Takuya, Dias, Mark, Henry, Shannan, Pittman, Brian, Ropchan, Jim, Nabulsi, Nabeel, Suridjan, Ivonne, Comley, Robert A., Huang, Yiyun, Finnema, Sjoerd J., Carson, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065227/
https://www.ncbi.nlm.nih.gov/pubmed/31953875
http://dx.doi.org/10.1002/ana.25682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065227/
https://www.ncbi.nlm.nih.gov/pubmed/31953875
http://dx.doi.org/10.1002/ana.25682

Ejemplares similares